PMHNP Scope of Practice for Weight Loss/GLP-1 in Georgia

If you’re a psychiatrist or psychiatric nurse practitioner considering adding weight management to your practice — or you’re already treating patients who’ve gained weight on psychotropics and want to help — you’re probably asking: Can I legally prescribe GLP-1s or other weight-loss meds via telehealth? What about controlled substances like phentermine? And does my state even allow this?

The short answer: Yes, psychiatrists can prescribe weight-loss medications, including via telehealth — but the rules vary wildly by state, your provider type, and whether the medication is a controlled substance.

Let’s cut through the confusion with what you actually need to know to practice safely and legally.

The Federal Landscape: DEA Rules for Telehealth Prescribing

Before COVID, federal law (the Ryan Haight Act) required an in-person medical exam before prescribing any controlled substance via telemedicine. That meant no remote prescriptions for stimulants, benzodiazepines, or appetite suppressants like phentermine without first seeing the patient face-to-face.

During the pandemic, the DEA waived this requirement. And here’s the key update for 2025: those flexibilities have been extended through December 31, 2026. Right now, you can prescribe Schedule II–V controlled substances via telehealth to new patients without an in-person visit, as long as you meet standard-of-care requirements and have a valid DEA registration.

But — and this is critical — this is temporary. The DEA is developing permanent rules that will likely require special telemedicine registrations or impose limits (like initial 30-day supplies for Schedule II meds). The clock is ticking, and once final rules drop, the landscape will shift again.

What This Means for Weight-Loss Prescribing

Most modern weight-loss medications — GLP-1 agonists like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) — are not controlled substances. You can prescribe them via telehealth right now in most states with no federal restrictions, as long as you establish a proper doctor-patient relationship and meet your state’s telehealth standards.

Phentermine (Adipex-P), however, is a Schedule IV controlled substance. Under the current DEA extension, you can prescribe it via telehealth — but your state may have additional rules (more on that below). And you’ll need to check your state’s Prescription Drug Monitoring Program (PDMP) before writing that prescription.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrist vs PMHNP: Scope of Practice for Weight Loss

Psychiatrists (MD/DO)

As a fully licensed physician, you have broad prescribing authority. There’s no ‘obesity license’ — if you’re competent to treat a condition and follow the standard of care, you can prescribe for it.

Practically speaking: You already manage weight gain from antipsychotics. Many psychiatrists prescribe metformin or other agents to counteract metabolic side effects. Prescribing a GLP-1 for weight management in a patient on olanzapine? Legally permissible, clinically reasonable.

The catch: Medical boards will hold you to the same standards as any obesity medicine specialist. That means:

• Documenting BMI and comorbidities
• Obtaining informed consent about risks/benefits
• Scheduling appropriate follow-ups (every 3 months minimum in states like Florida)
• Incorporating lifestyle counseling or referring to nutrition specialists

You’re not expected to become a bariatric specialist overnight, but you are expected to practice competently. Some psychiatrists pursue certification through the American Board of Obesity Medicine to bolster their credentials.

PMHNPs and Psychiatric NPs

This is where scope gets murky. Your licensure and training are in mental health, not metabolic disease. Prescribing purely for obesity — especially running a standalone weight-loss practice — may be viewed by some state nursing boards as outside your scope.

State-by-state reality:

• Texas & Florida: You’ll likely need a supervising physician with appropriate expertise (family practice, endocrinology) to prescribe weight-loss medications under a delegation or collaborative agreement
• California: NPs with AB 890 independent practice authority (effective 2026) could theoretically manage weight loss, but if you’re a psych-certified NP rather than family NP, expect professional risk without additional training
• New York: After 3,600 hours of practice, you can work independently — but treating obesity may still be seen as outside your usual scope without collaboration

Bottom line for NPs: If you want to add weight management, either work under explicit physician protocols that include obesity treatment, pursue dual certification, or partner with a primary care physician who can provide oversight.

State-Specific Rules That Actually Matter

Here’s where the rubber meets the road. Federal rules set the floor; state rules often set the ceiling — and some states have built that ceiling much lower.

New York: The Strictest Standard

New York requires an in-person medical evaluation before prescribing any controlled substance — even with the federal DEA waiver. The only exceptions:

• Another NY provider examined the patient in-person within the past 12 months and shared records
• You’re covering for a colleague who saw the patient in person
• Emergency situation with an existing patient (5-day supply max)

What this means: You cannot start a New York patient on phentermine via telehealth alone. You’ll need a hybrid model — either see them in person first, or coordinate with a local provider who can.

For non-controlled weight-loss meds like GLP-1s? You’re fine prescribing via video in New York. But you must also:

• Check the state PMP within 24 hours before prescribing any Schedule II–IV drug
• Use electronic prescribing (mandatory for all prescriptions in NY)
• Document a thorough evaluation equivalent to in-person care

Florida: Permissive, But With Specific Rules

Florida is friendlier to telehealth — with detailed requirements for weight-loss prescribing:

Obesity treatment standards (applies to ALL providers):

• Patient must have BMI ≥30 (or ≥27 with comorbidities)
• Must obtain written informed consent outlining medication risks
• Must provide a copy of Florida’s ‘Weight-Loss Consumer Bill of Rights’ to each patient
• Must re-evaluate patients at least every 3 months while on obesity medications

Controlled substances: Florida prohibits teleprescribing Schedule II drugs (like Adderall) — except for psychiatric treatment. So you can prescribe stimulants for ADHD via telehealth, but not for weight loss. Phentermine (Schedule IV) is allowed via telehealth.

NP/PA scope: APRNs need physician collaboration unless they have autonomous practice status (limited to certain experienced Family NPs). Psych NPs still require physician supervision — and that physician should have relevant expertise in obesity treatment.

California: Progressive Telehealth, Strict Corporate Practice

California allows telehealth to establish a valid doctor-patient relationship with no in-person requirement — if you meet the standard of care.

Key requirements:

• Documented patient consent for telehealth (California B&P Code §2290.5)
• Check the CURES PDMP before first prescription of any Schedule II–IV drug and every 4 months thereafter
• All prescriptions must be electronic

The corporate practice trap: Only physician-owned professional corporations can provide medical services in California. If you’re thinking about a telehealth weight-loss startup, you can’t just hang a shingle as an LLC — you need proper physician ownership structure.

NP scope: California is implementing AB 890, which will allow certain experienced NPs to practice independently by 2026. But if you’re a psych NP rather than family NP, treating obesity independently remains risky without additional credentials.

Texas: Standard-of-Care Focus

Texas has no blanket prohibition on telehealth prescribing and no state-mandated in-person visit — but expects you to establish a proper relationship via live video (or equivalent technology that meets the standard of care).

Practical requirements:

• Document a thorough evaluation like you would in person
• Check the Texas PMP before prescribing controlled substances (required for opioids/benzos; best practice for all controlled meds)
• Send a report to the patient’s primary care physician within 72 hours (with patient consent)

NP/PA rules: You must have a Prescriptive Authority Agreement with a Texas-licensed physician. That agreement must explicitly include weight-loss medications if you plan to prescribe them.

Pennsylvania & Illinois: Following Federal Lead

Both states largely defer to federal law for telehealth prescribing, with some state-specific PDMP requirements:

Pennsylvania:

• Check PA PDMP before first opioid/benzo prescription and each time for ongoing therapy
• NPs require collaborative agreements (no independent practice yet)
• No specific obesity treatment rules; follow standard medical practice

Illinois:

• Supports telehealth broadly, including audio-only in some cases
• Full Practice Authority available for experienced APRNs (can prescribe independently after 4,000 hours)
• Check Illinois PMP for Schedule II narcotics; recommended for all controlled substances

The Economics of Weight-Loss Telehealth: Why Platforms Beat DIY Marketing

Let’s talk money, because this matters for your practice decision.

Many providers assume they can just throw up a website, run some Google Ads, and start seeing cash-pay weight-loss patients. The reality is far more expensive and uncertain than most expect.

The Real Cost of DIY Patient Acquisition

When you factor in all costs of acquiring a qualified psychiatric or weight-loss patient through self-marketing:

• Google Ads: Mental health and weight-loss keywords run $15–40+ per click. Most clicks don’t convert to booked patients. Realistic cost per booked patient: $200–400+
• SEO: Takes 6–12 months of consistent investment before generating meaningful patient flow — and requires expertise most solo providers don’t have
• Directory listings: Psychology Today, Zocdoc, etc. charge monthly fees ($100–300+) AND you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35–100+) on top of subscription costs
• Agency/consultant fees: If you hire experts, add $2,000–5,000/month for professional marketing
• Staff time: Qualifying leads, handling no-shows from cold traffic, following up
• Failed campaigns: Most first attempts at PPC or SEO don’t work — that’s wasted money

Bottom line: Expect to spend $3,000–5,000/month on marketing with uncertain results for the first 6–12 months. For most providers — especially those starting out or scaling — that’s a significant gamble.

The Platform Alternative

Platforms like Klarity Health flip the model: instead of gambling thousands on marketing that might not work, you pay only when a qualified patient books with you.

Key advantages:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

The economic case is clear: instead of spending $3,000–5,000/month with uncertain ROI, you pay a standard listing fee per new patient lead only when that patient books. That’s guaranteed ROI vs gambling on marketing channels.

For weight-loss specifically: Platforms handle the patient acquisition, insurance verification, and scheduling logistics — letting you focus on clinical care rather than learning Google Ads optimization.

Compliance Checklist: Stay Legal Across States

Whether you’re prescribing GLP-1s for antipsychotic-related weight gain or running a dedicated weight-management practice, follow these universal best practices:

1. Verify patient location at each visit

Ensure you’re licensed in the state where the patient is physically located. Use intake forms that capture current location, not just billing address.

2. Document telehealth consent

Required in California, Illinois, and recommended everywhere. A simple documented conversation: ‘I’m explaining this visit is via telehealth, we’ll use secure video, you understand the limitations…’

3. Conduct and document a thorough evaluation

State medical boards review telehealth records to verify adequate exams. For weight loss, document:

• Current weight and BMI
• Medical history (thyroid, diabetes, cardiovascular)
• Current medications and potential interactions
• Lifestyle factors (diet, exercise, sleep)
• Mental health status (especially if prescribing stimulants)

4. Follow state-specific protocols

• Florida: Quarterly follow-ups, written informed consent, Consumer Bill of Rights
• New York: In-person exam for controlled substances, PMP check within 24 hours
• California: CURES check every 4 months for ongoing controlled Rx
• Texas: PMP documentation, care coordination with PCP

5. Use PDMPs and e-prescribing

Not just legal requirements — critical patient safety checks. Most states now require electronic prescribing for controlled substances.

6. Incorporate lifestyle counseling

States like New Jersey explicitly require documentation of nutrition and exercise counseling alongside weight-loss prescriptions. Even where not legally mandated, it’s the standard of care.

7. Coordinate with primary care

Send records to the patient’s PCP (with consent). This protects you legally and ensures continuity of care — especially important if the patient develops side effects or metabolic complications.

FAQ: Weight-Loss Prescribing for Psychiatrists

Can I prescribe Ozempic or Wegovy for weight loss via telehealth?

Yes, in most states. GLP-1 agonists are not controlled substances, so federal DEA restrictions don’t apply. You must:

• Be licensed in the patient’s state
• Conduct an appropriate telehealth evaluation (usually video)
• Follow your state’s telehealth and prescribing standards
• Document medical necessity (BMI, comorbidities, failed lifestyle interventions)

Do I need an in-person visit to prescribe phentermine?

Depends on your state:

• New York: Yes, in-person exam required for any controlled substance
• Florida, Texas, California, Pennsylvania, Illinois: No in-person requirement under current federal extension (through Dec 2026), but you must establish a valid telehealth relationship and check state PDMP

As a PMHNP, can I offer weight-loss treatment?

Usually requires physician collaboration or additional certification. Key factors:

• Your state’s scope of practice laws (varies significantly)
• Whether you have independent practice authority
• The expertise of your collaborating physician (should be in relevant field like family medicine)
• Your own training and competence in obesity medicine

Consider pursuing additional certification or limiting practice to patients where weight management overlaps with psychiatric care (e.g., managing metabolic side effects of psychotropics).

What happens when the DEA extension ends in 2026?

Expect new rules requiring special telemedicine registrations or other requirements for prescribing controlled substances. Stay current with DEA announcements. For weight-loss practice, this mainly affects phentermine and other controlled appetite suppressants — GLP-1s will remain unaffected.

How do I handle insurance vs cash-pay for weight-loss meds?

Insurance coverage for weight-loss medications varies widely:

• Many plans cover GLP-1s for diabetes but not obesity
• California’s Medi-Cal will stop covering GLP-1s for weight loss in 2026
• Prior authorization requirements are common and time-consuming

Many telehealth providers operate on cash-pay models to avoid insurance hassles. Be transparent about costs upfront (Florida requires written price quotes).

Can I prescribe compounded semaglutide?

Legally yes (if you follow state pharmacy laws), but professionally risky. Compounded drugs lack FDA approval for safety/efficacy. Primary care physicians have raised concerns about telehealth providers prescribing unproven compounded versions. If you do prescribe compounded medications, document clearly why FDA-approved versions aren’t appropriate and ensure the compounding pharmacy is reputable.

The Bottom Line: Adding Weight Management to Your Psychiatric Practice

Weight-loss prescribing via telehealth is legally permissible for psychiatrists in most states — but requires navigating complex, state-specific regulations. Here’s the smart approach:

Start narrow: Focus on patients where weight management overlaps with psychiatric care (metabolic side effects of psychotropics, binge-eating disorder comorbid with obesity). This keeps you firmly in your scope of practice.

Partner appropriately: If expanding beyond that, work with physician colleagues or platforms that handle compliance and patient acquisition. Trying to DIY marketing and multi-state licensing is expensive and risky.

Stay current: Regulations are evolving rapidly. The DEA extension runs through 2026, but permanent rules are coming. State medical boards are increasingly scrutinizing telehealth weight-loss services. Subscribe to updates from your state medical board and DEA.

Document obsessively: Telehealth records face more scrutiny than in-person visits. When in doubt, over-document your clinical reasoning, informed consent discussions, and coordination with other providers.

Consider a platform approach: Instead of gambling thousands on marketing with uncertain results, platforms like Klarity Health let you see pre-qualified patients and pay only when they book — eliminating the financial risk while you focus on clinical care.

The demand for accessible, effective weight management is real. As a psychiatric prescriber, you’re uniquely positioned to help patients struggling with both mental health and metabolic challenges. Just make sure you’re doing it legally, safely, and sustainably.

Ready to see qualified patients without the marketing headaches? Join Klarity’s provider network to connect with patients seeking psychiatric and weight management care — with built-in compliance support and pay-per-appointment economics that actually work.

References

1. U.S. Department of Health & Human Services. ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026.’ January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Florida Statutes § 456.47 – Use of Telehealth to Provide Services (Florida Telehealth Act). Effective 2019. http://www.leg.state.fl.us/statutes/

3. Florida Administrative Code 64B8-9.012 – Standards for the Prescription of Drugs to Treat Obesity. Effective August 8, 2022. https://regulations.justia.com/states/florida/64/64b8/chapter-64b8-9/section-64b8-9-012/

4. Goodwin Law. ‘A Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs.’ March 30, 2024. https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-hltc-changing-regulatory-reimbursement-weight-loss-drugs

5. California Medical Association. ‘GLP-1 medications for weight loss will no longer be covered by Medi-Cal.’ December 2, 2025. https://www.cmadocs.org/newsroom/news/view/ArticleId/51074/GLP-1-medications-for-weight-loss-will-no-longer-be-covered-by-Medi-Cal

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.cchpca.org/topic/online-prescribing/#:~:text=No%20controlled%20substance%20shall%20be,for%20the%20medical%20evaluation%2C%20and
• https://florida.public.law/statutes/fla.stat.456.47#:~:text=provider%20is%20not%20required%20to,is%20prescribed%20for%20the%20following
• https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-hltc-changing-regulatory-reimbursement-weight-loss-drugs#:~:text=Florida%20law%20restricts%20the%20prescribing,5
• https://www.ofdigitalinterest.com/2023/09/weight-loss-programs-in-florida-state-law-considerations-for-glp-1-telehealth-providers/#:~:text=2000%20%28Fla,loss%20providers%20are%20required%20to
• https://www.medicaldirectorco.com/california-weight-loss-clinic-and-telehealth-compliance-guide-2025/#:~:text=medical%20director%20and%20retain%20full,Clinics%20must%20maintain%20DEA
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,require%20DEA%20registration
• https://www.fiercehealthcare.com/providers/primary-care-doctors-concerned-about-patient-risks-telehealth-prescribers-glp-1s-survey#:~:text=Primary%20care%20physicians%20are%20mainly,cited%20by%20half%20of%20physicians
• https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-hltc-changing-regulatory-reimbursement-weight-loss-drugs#:~:text=New%20Jersey%20law%20requires%20that,and%20identify%20the%20risks%20associated